<div>
  <ul>
    <li>
      <p>
        Israeli AI drug discovery startup Protai has raised an additional USD 12 million in seed funding, bringing the total seed funds to USD 20 million (the previous round closed in January 2022). The extension was ​​led by Grove Ventures and Pitango HealthTech, with participation from Maj Invest Equity Fund.
      </p>
    </li>
    <li>
      <p>
        The proceeds will be directed toward expanding the company&rsquo;s oncology pipeline, improving its databases, and pursuing partnerships with other pharmaceutical companies.
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://www.finsmes.com/2023/03/protai-raises-additional-12m-in-seed-funding.html">
      FinSMEs
    </a>
  </p>
  <p>
    <a href="https://hitconsultant.net/2023/03/15/protai-raises-20m-to-build-an-oncology-drug-discovery-pipeline/">
      HIT Consultant
    </a>
  </p>
</div>


All Updates

Protai raises additional USD 12 million in seed funding

Protai emerges from stealth with USD 8 million seed funding